Skip to content

Effect of dexmedetomidine for gynecological laparoscopy intravenous analgesia

Effect of dexmedetomidine alone for intravenous patient-controlled analgesia after gynecological laparoscopic surgery

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-15006212
Enrollment
Unknown
Registered
2015-04-07
Start date
2015-04-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Tumor

Interventions

Group D:dexmedetomidine analgesia
Group F:fentanyl analgesia

Sponsors

Shandong Provincial Cancer Hospital and Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 20–60 years with an American Society of Anesthesiologists (ASA) physical status I-II who underwent gynecological laparoscopy surgery will be recruited into this study

Exclusion criteria

Exclusion criteria: Patients have significant pulmonary disease, significant cardiac dysfunction (left ventricular ejection fraction 35kg m-2, a long history of opioid analgesic use or NSAIDS, tranquilizer use, psychiatric disorders, bradycardia with cardiac conduction or rhythm abnormalities will be excluded from the study. Individuals will be subsequently excluded from the study if who need to open abdominal conversion or who require reoperation due to postoperative bleeding or others.

Design outcomes

Primary

MeasureTime frame
Visual analog scale pain score;the observer's assessment of alertness sedation scale;

Secondary

MeasureTime frame
satisfaction;recovery of gastrointestinal function;

Countries

China

Contacts

Public ContactXiuqin Wang
jasmine75@163.com+86 0531-67626222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026